NCT05311527 is a NA clinical trial of Urolift in Prostate Cancer, sponsored by University of Texas Southwestern Medical Center.

Who is sponsoring NCT05311527?

NCT05311527 is sponsored by University of Texas Southwestern Medical Center.

What drugs are being tested in NCT05311527?

Interventions in NCT05311527: Urolift, SABR.

What condition does NCT05311527 study?

NCT05311527 studies Prostate Cancer.

Is NCT05311527 still recruiting?

NCT05311527 is currently completed. Last updated 31 October 2025.

Last reviewed 2025-10-31 · How we verify

NCT05311527

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

UroLift System With SAbR for Prostate Cancer and BPH

Completed NA Last updated 31 October 2025

What this trial tests

NA trial testing Urolift in Prostate Cancer in 15 participants. Completed in 29 October 2025.

Timeline

11 January 2023

Primary endpoint
29 October 2025

29 October 2025

Quick facts

Lead sponsor	University of Texas Southwestern Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	11 January 2023
Primary completion	29 October 2025
Estimated completion	29 October 2025
Sites	1 location across United States

Drugs / interventions tested

Urolift
SABR

Conditions studied

Prostate Cancer — all drugs for Prostate Cancer →

Sponsor

University of Texas Southwestern Medical Center

Who can join

45 and older, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Confirming safety of combining UroLift System prior to SAbR for patients with newly diagnosed prostate cancer and a history of BPH, by measuring the acute complication rate of UroLift System implant in patients with BPH undergoing SAbR (within 90 days of treatment completion)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Management of lower urinary tract symptoms before prostate cancer radiotherapy: a call for innovative strategies.
Le Guevelou J, Anract J, Dariane C, Scheltema M, et al · · 2026 · PMID 42059970 · DOI 10.1007/s00345-026-06427-9

Verify or expand the search:

Other recruiting trials for Prostate Cancer

Currently open trials in the same condition.

NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

NCT03849963 — Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain · recruiting
NCT06917183 — Developing Strategies for Implementation and Use of the Operating Room Black Box (ORBB) · NA · not yet recruiting
NCT05145309 — Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans · Phase 2 · not yet recruiting
NCT06552000 — Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer · NA · not yet recruiting
NCT07387666 — Imaging Acetadote Metabolism in Glioblastoma · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05311527 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas Southwestern Medical Center
Last refreshed: 31 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05311527.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing